NCT03055897View on ClinicalTrials.gov

Tear Film Innovations iLux Safety Study

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 3, 2016

Primary Completion Date

May 17, 2016

Study Completion Date

May 18, 2016

Conditions
Meibomian Gland DysfunctionEvaporative Dry Eye
Interventions
DEVICE

iLux 2020 System

Medical device that applies localized heat and pressure therapy to the eyelid in order to express melted meibum from obstructed glands

Trial Locations (1)

92924

TearFilm Innovations Investigative Site, Encinitas

All Listed Sponsors
lead

Tear Film Innovations, Inc.

INDUSTRY

NCT03055897 - Tear Film Innovations iLux Safety Study | Biotech Hunter | Biotech Hunter